Urinary Catheters Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Urinary Catheters Pipeline Market Report Overview

A Urinary Catheter is a tube system to drain and collect urine from the bladder. These are used to manage urinary incontinence and urinary retention in both men and women. The Urinary Catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·        Foley Catheters

·        External Urinary Catheters

·        Suprapubic Catheters

Key Territories ·        The US

·        Europe

·        Canada

·        China

·        Taiwan

Key Regulatory Paths ·        510(k)

·        CE

·        UKCA

·        MDL

·        NMPA

Leading Companies ·        All India Institute of Medical Sciences

·        Aurie

·        Biocrede Inc

·        BioModics ApS

·        Brighton Development LLC

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Urinary Catheters Pipeline Market by Segments

The key segments in the Urinary Catheters pipeline market are Foley Catheters, External Urinary Catheters, and Suprapubic Catheters. As of December 2023, Foley Catheters accounted for the highest number of pipeline products.

Urinary Catheters Pipeline Market Analysis by Segments, 2023 (%)

Urinary Catheters Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment Insights into the Urinary Catheters Pipeline Market

Download a Free Report Sample

Urinary Catheters Pipeline Market Segmentation by Territories

A few of the key territories for Urinary Catheters pipeline products are the US, Europe, Canada, China, and Taiwan among others. As of December 2023, the US accounted for the highest number of pipeline products.

Urinary Catheters Pipeline Market Analysis by Territories, 2023 (%)

Urinary Catheters Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Urinary Catheters Pipeline Market

Download a Free Report Sample

Urinary Catheters Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths followed by the Urinary Catheters pipeline market are 510(k), CE, UKCA, MDL, and NMPA among others. As of December 2023, 510(k) was the most followed pathway for pipeline products in the market.

Urinary Catheters Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Urinary Catheters Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Urinary Catheters Pipeline Market

Download a Free Report Sample

Urinary Catheters Pipeline Market – Competitive Landscape

A few of the key companies associated with the Urinary Catheters pipeline market are All India Institute of Medical Sciences, Aurie, Biocrede Inc, BioModics ApS, and Brighton Development LLC, among others.

All India Institute of Medical Sciences (AIIMS): AIIMS is headquartered in New Delhi, India. It is a medical institution that provides medical education, biomedical research, and healthcare services. AIIMS offers many services such as research, teaching, medical, nursing, and laboratory services among others. The institution also provides DM (Doctorate of Medicine) and MCh (Master of Chirurgiae) super specialty courses in the areas of cardiology, gastroenterology, endocrinology, cardiothoracic, and neurosurgery among others. AIIMS conducts research in the fields of neurosciences, genetics, and computer simulation of hormone-receptor interaction. It applies DNA recombinant technology, immunology, and electron microscopy to study diseases such as leprosy, malaria, fluorosis, and iodine deficiency.

Urinary Catheters Pipeline Market Analysis by Companies, 2023

Urinary Catheters Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Urinary Catheters Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Urinary Catheters Pipeline Market Segments Outlook

  • Foley Catheters
  • External Urinary Catheters
  • Suprapubic Catheters

Urinary Catheters Pipeline Market Territories Outlook

  • The US
  • Europe
  • Canada
  • China
  • Taiwan

Urinary Catheters Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • UKCA
  • MDL
  • NMPA

Scope

This report provides:

  • An extensive coverage of the Urinary Catheters under development.
  • An exhaustive list of major pipeline products and their details, including product descriptions, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of Urinary Catheters and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report will enable you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Urinary Catheters under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

All India Institute of Medical Sciences
Aurie
Biocrede Inc
BioModics ApS
Brighton Development LLC
Camstent Ltd
Ceragenix Pharmaceuticals, Inc. (Inactive)
Chain Antimicrobials Ltd
Coloplast A/S
Control Flo Medical LLC
ConvaTec Group Plc
Dongguan TT Medical Inc
Enox Biopharma Inc (Inactive)
Flat Medical Inc
Flume Catheter Co Ltd
FocusStart LLC
Ingenion Medical Ltd
InterVaal Pte Ltd
Laborie Medical Technologies Inc
Leading Age Supplies LLC
Montana State University
N8 Medical LLC
Olympus Endo Technology America Inc
OTU Medical Inc
Provenmed
Pyriscence LLC
Riocath Global AS
Sharklet Technologies Inc
The University of Nottingham
Tractivus SL
University of Amsterdam
University of California San Diego
University of South Florida
University of Texas Health Science Center at San Antonio
University of Utah
UroDeflect
UroDev Medical
Xennovate Medical LLC

Table of Contents

1 Table of Contents 3

1.1 List of Tables 7

1.2 List of Figures 10

2 Introduction 11

2.1 Urinary Catheters Overview 11

3 Products under Development 12

3.1 Urinary Catheters – Pipeline Products by Stage of Development 12

3.2 Urinary Catheters – Pipeline Products by Segment 13

3.3 Urinary Catheters – Pipeline Products by Territory 14

3.4 Urinary Catheters – Pipeline Products by Regulatory Path 15

3.5 Urinary Catheters – Pipeline Products by Estimated Approval Date 16

3.6 Urinary Catheters – Ongoing Clinical Trials 17

4 Urinary Catheters – Pipeline Products under Development by Companies 18

4.1 Urinary Catheters Companies – Pipeline Products by Stage of Development 18

4.2 Urinary Catheters – Pipeline Products by Stage of Development 20

5 Urinary Catheters Companies and Product Overview 22

5.1 All India Institute of Medical Sciences Company Overview 22

5.1.1 All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 22

5.2 Aurie Company Overview 23

5.2.1 Aurie Pipeline Products & Ongoing Clinical Trials Overview 23

5.3 Biocrede Inc Company Overview 24

5.3.1 Biocrede Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.4 BioModics ApS Company Overview 25

5.4.1 BioModics ApS Pipeline Products & Ongoing Clinical Trials Overview 25

5.5 Brighton Development LLC Company Overview 26

5.5.1 Brighton Development LLC Pipeline Products & Ongoing Clinical Trials Overview 26

5.6 Camstent Ltd Company Overview 27

5.6.1 Camstent Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

5.7 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 30

5.7.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30

5.8 Chain Antimicrobials Ltd Company Overview 31

5.8.1 Chain Antimicrobials Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

5.9 Coloplast A/S Company Overview 32

5.9.1 Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview 32

5.10 Control Flo Medical LLC Company Overview 36

5.10.1 Control Flo Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 36

5.11 ConvaTec Group Plc Company Overview 37

5.11.1 ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 37

5.12 Dongguan TT Medical Inc Company Overview 40

5.12.1 Dongguan TT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.13 Enox Biopharma Inc (Inactive) Company Overview 41

5.13.1 Enox Biopharma Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 41

5.14 Flat Medical Inc Company Overview 42

5.14.1 Flat Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.15 Flume Catheter Co Ltd Company Overview 44

5.15.1 Flume Catheter Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

5.16 FocusStart LLC Company Overview 47

5.16.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 47

5.17 Ingenion Medical Ltd Company Overview 48

5.17.1 Ingenion Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

5.18 InterVaal Pte Ltd Company Overview 50

5.18.1 InterVaal Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

5.19 Laborie Medical Technologies Inc Company Overview 51

5.19.1 Laborie Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.20 Leading Age Supplies LLC Company Overview 52

5.20.1 Leading Age Supplies LLC Pipeline Products & Ongoing Clinical Trials Overview 52

5.21 Montana State University Company Overview 53

5.21.1 Montana State University Pipeline Products & Ongoing Clinical Trials Overview 53

5.22 N8 Medical LLC Company Overview 54

5.22.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 54

5.23 Olympus Endo Technology America Inc Company Overview 55

5.23.1 Olympus Endo Technology America Inc Pipeline Products & Ongoing Clinical Trials Overview 55

5.24 OTU Medical Inc Company Overview 56

5.24.1 OTU Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 56

5.25 Provenmed Company Overview 59

5.25.1 Provenmed Pipeline Products & Ongoing Clinical Trials Overview 59

5.26 Pyriscence LLC Company Overview 60

5.26.1 Pyriscence LLC Pipeline Products & Ongoing Clinical Trials Overview 60

5.27 Riocath Global AS Company Overview 61

5.27.1 Riocath Global AS Pipeline Products & Ongoing Clinical Trials Overview 61

5.28 Sharklet Technologies Inc Company Overview 66

5.28.1 Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 66

5.29 The University of Nottingham Company Overview 67

5.29.1 The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 67

5.30 Tractivus SL Company Overview 68

5.30.1 Tractivus SL Pipeline Products & Ongoing Clinical Trials Overview 68

5.31 University of Amsterdam Company Overview 69

5.31.1 University of Amsterdam Pipeline Products & Ongoing Clinical Trials Overview 69

5.32 University of California San Diego Company Overview 70

5.32.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 70

5.33 University of South Florida Company Overview 71

5.33.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 71

5.34 University of Texas Health Science Center at San Antonio Company Overview 72

5.34.1 University of Texas Health Science Center at San Antonio Pipeline Products & Ongoing Clinical Trials Overview 72

5.35 University of Utah Company Overview 73

5.35.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 73

5.36 UroDeflect Company Overview 74

5.36.1 UroDeflect Pipeline Products & Ongoing Clinical Trials Overview 74

5.37 UroDev Medical Company Overview 75

5.37.1 UroDev Medical Pipeline Products & Ongoing Clinical Trials Overview 75

5.38 Xennovate Medical LLC Company Overview 78

5.38.1 Xennovate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 78

6 Urinary Catheters- Recent Developments 79

6.1 Nov 14, 2023: SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update 79

6.2 Nov 13, 2023: INVO Reports Record Third Quarter 2023 Financial Results 81

6.3 Nov 09, 2023: Coloplast Reports Annual Report 2022/23 83

6.4 Nov 07, 2023: ProstaLund Announces Interim Report 83

6.5 Nov 05, 2023: Teleflex Reports Third Quarter Financial Results, Full Year 2023 Outlook 84

6.6 Nov 02, 2023: Dentsply Sirona Announces Appointment of Mr. Brian Gladden as New Board Member 85

6.7 Oct 27, 2023: Bactiguard Holding Announces Interim Report Q3 2023 85

6.8 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023 87

6.9 Oct 10, 2023: HR Pharmaceuticals, Significantly Expands the Trucath Portfolio With Two New Offerings of Ready-To-Use Intermittent Catheters Delivering Optimal Protection, Comfort, and Convenience 89

6.10 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 89

6.11 Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer 90

6.12 Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources 90

6.13 Sep 08, 2023: Coloplast Receives 510(k) Clearance for Luja 90

6.14 Aug 31, 2023: Sanofi Appoints a Venture Investor to R&D Head as Executive Team Expands 91

6.15 Aug 29, 2023: Coloplast Launches Offering to Raise Around Dkk 9 Billion Through Issue of New B Shares in a Directed Issue and Private Placement 91

6.16 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 92

6.17 Aug 18, 2023: Coloplast Receives 510(k) Clearance for Self-Cath Closed System 92

6.18 Aug 15, 2023: Convatec Group Appoints Robyn Butler-Mason as Company Secretary 93

6.19 Aug 10, 2023: Teleflex Medical Receives 510(k) Clearance for Rusch SoftSimplastic Foley Catheter 93

6.20 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 93

6.21 Aug 03, 2023: Teleflex Reports Second Quarter Financial Results and Full Year 2023 Outlook 93

6.22 Aug 02, 2023: ConvaTec Group Announces Interim Results for the six months ended 30 June 2023 97

6.23 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility 97

6.24 Jul 19, 2023: Boston Scientific Lays off 52 Amid California Facility Closure 97

6.25 Jul 12, 2023: Flume Catheter Receives Additional 510(k) Clearance for Flume Catheter 98

6.26 Jun 28, 2023: Medline Announces Leadership Transition Naming New CEO and President & COO 98

6.27 Jun 26, 2023: Covalon Announces Participation in APIC Annual Conference & Exposition on June 26 – 28, 2023 in Orlando, Florida 98

6.28 Jun 13, 2023: Well Lead Medical Receives Additional 510(k) Clearance for PVC Hydrophilic Urethral Catheter 99

6.29 May 16, 2023: Dentsply Sirona receives 510(k) clearance for GentleCath Hydrophilic Catheter 99

6.30 May 16, 2023: Wellspect receives 510(k) clearance for SimPro Now Hydrophilic Catheter 100

6.31 May 15, 2023: INVO reports Q1 2023 financial results 100

6.32 May 15, 2023: SeaStar Medical reports Q1 2023 financial results and provides a business update 102

6.33 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 104

6.34 May 05, 2023: Bactiguard Holding: Bulletin from annual general meeting 2023 104

6.35 May 04, 2023: Teleflex reports first quarter financial results and full year 2023 outlook 105

6.36 Apr 28, 2023: Research study on comfort of the new FLUME catheter to begin recruitment 106

6.37 Apr 27, 2023: Bactiguard Holding report for the first quarter 2023 107

6.38 Apr 20, 2023: Hangzhou Jimushi Meditech receives 510(k) clearance for Intermittent Nelaton Catheter For Single Use 109

6.39 Apr 20, 2023: Teleflex announces first quarter 2023 earnings conference call information 109

6.40 Apr 17, 2023: INVO Reports Fourth Quarter and Full Year 2022 Financial Results 109

6.41 Apr 12, 2023: Medtronic has a layoff in California 111

6.42 Apr 10, 2023: Henry Ford Health Appoints New Orthopedics Chair and Medical Director 111

6.43 Apr 05, 2023: Bactiguard Holding Annual Report 2022 112

6.44 Apr 03, 2023: Notice to attend the Annual General Meeting of Bactiguard Holding AB 113

6.45 Mar 31, 2023: Study shows significant improvement in bladder emptying with Coloplast’s Luja compared to competitor catheter 114

6.46 Mar 30, 2023: INVO Provides Preliminary Update on FY2022 Financial Results 115

6.47 Mar 22, 2023: ConvaTec Group Notice of Annual General Meeting 116

6.48 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 117

6.49 Mar 09, 2023: ConvaTec Group Announces Annual Results for the twelve months ended 31 December 2022 117

6.50 Mar 09, 2023: Covalon Announces Voting Results from Fiscal 2022 Annual and Special Meeting of Shareholders 118

6.51 Feb 23, 2023: Teleflex Reports Fourth Quarter and Full Year 2022 Financial Results 119

6.52 Feb 21, 2023: Teleflex to Present at the 44th Annual Raymond James Institutional Investors Conference 123

6.53 Feb 09, 2023: Teleflex Announces Fourth Quarter 2022 Earnings Conference Call Information 123

6.54 Feb 03, 2023: Coloplast launches male catheter designed to reduce the risk of urinary tract infections 123

6.55 Feb 03, 2023: Coloplast Announcement Interim Financial Report Q1 2022/23 124

6.56 Jan 31, 2023: Coloplast Finance Announces Annual General Meeting Decisions 125

6.57 Jan 25, 2023: Dentsply Sirona Is Said to Weigh $1 Billion Split of Wellspect 125

6.58 Jan 10, 2023: Bactiguard receives first MDR product approval 125

6.59 Dec 20, 2022: Hollister receives 510(k) clearance for Sleeved IC 126

6.60 Dec 19, 2022: Chengdu Daxan Innovative Medical Tech receives 510(k) clearance for PVC Hydrophilic Urethral Catheter 126

6.61 Dec 08, 2022: Coloplast receives 510(k) clearance for Self-Cath 126

6.62 Dec 07, 2022: Silq Technologies receives additional 510(k) clearance for 2-Way 100% Silicone ClearTract Catheter 126

6.63 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer 127

7 Appendix 128

7.1 Methodology 128

7.2 About GlobalData 131

7.3 Contact Us 131

7.4 Disclaimer 131

Table

Urinary Catheters – Pipeline Products by Stage of Development 12

Urinary Catheters – Pipeline Products by Segment 13

Urinary Catheters – Pipeline Products by Territory 14

Urinary Catheters – Pipeline Products by Regulatory Path 15

Urinary Catheters – Pipeline Products by Estimated Approval Date 16

Urinary Catheters – Ongoing Clinical Trials 17

Urinary Catheters Companies – Pipeline Products by Stage of Development 18

Urinary Catheters – Pipeline Products by Stage of Development 20

All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 22

Super Hydrophobic Catheter – Product Status 22

Super Hydrophobic Catheter – Product Description 22

Aurie Pipeline Products & Ongoing Clinical Trials Overview 23

Reusable Intermittent Catheter System – Product Status 23

Reusable Intermittent Catheter System – Product Description 23

Biocrede Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Urinary Catheter – Product Status 24

Urinary Catheter – Product Description 24

BioModics ApS Pipeline Products & Ongoing Clinical Trials Overview 25

Indwelling Urinary Catheter – Product Status 25

Indwelling Urinary Catheter – Product Description 25

Brighton Development LLC Pipeline Products & Ongoing Clinical Trials Overview 26

Antimicrobial Catheter – Catheter Associated Urinary Tract Infection – Product Status 26

Antimicrobial Catheter – Catheter Associated Urinary Tract Infection – Product Description 26

Camstent Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

Camstent Coated Foley Catheter – Product Status 27

Camstent Coated Foley Catheter – Product Description 27

Camstent Ltd – Ongoing Clinical Trials Overview 28

Camstent Coated Foley Catheter – A Prospective Multicentre Randomized Study to Assess the Impact of a Catheter Coating on Clinical Bacteriuria 29

Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30

Cerashield Coated Silicone Urinary Catheter – Product Status 30

Cerashield Coated Silicone Urinary Catheter – Product Description 30

Chain Antimicrobials Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

Peptide-Coated Catheter – Product Status 31

Peptide-Coated Catheter – Product Description 31

Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview 32

Luja – Product Status 32

Luja – Product Description 33

Single-Use Compact Female Intermittent Catheter – Product Status 33

Single-Use Compact Female Intermittent Catheter – Product Description 33

Coloplast A/S – Ongoing Clinical Trials Overview 34

Single-Use Compact Female Intermittent Catheter – A Randomized, Open-labelled, Crossover Study Confirming Performance of a New Single-use Compact Intermittent Catheter in a Population of Adult Female Intermittent Catheter Users 35

Control Flo Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 36

ResQ Urological Catheter System – Product Status 36

ResQ Urological Catheter System – Product Description 36

ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 37

GentleCath Air Female – Product Status 37

GentleCath Air Female – Product Description 37

ConvaTec Group Plc – Ongoing Clinical Trials Overview 38

GentleCath Air Female – GentleCath Air Intermittent Catheter Smartwatch Real Life Pilot Study 39

Dongguan TT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 40

Drug-coated Catheter – Product Status 40

Drug-coated Catheter – Product Description 40

Enox Biopharma Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 41

Self-Sterilizing Urinary Catheter – Product Status 41

Self-Sterilizing Urinary Catheter – Product Description 41

Flat Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 42

UroAid – F – Product Status 42

UroAid – F – Product Description 42

UroAid – IV – Product Status 43

UroAid – IV – Product Description 43

Flume Catheter Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

Flume Catheter – Product Status 44

Flume Catheter – Product Description 44

Flume Catheter Co Ltd – Ongoing Clinical Trials Overview 45

Flume Catheter – FLUME Catheter Comfort Study 46

FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 47

Anti-biofilm Urological Catheter – Product Status 47

Anti-biofilm Urological Catheter – Product Description 47

Ingenion Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

CymActive SealSoft Bladder Management System – Product Status 48

CymActive SealSoft Bladder Management System – Product Description 48

FemActive Catheter – Product Status 49

FemActive Catheter – Product Description 49

InterVaal Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

InterVaal Catheter – Product Status 50

InterVaal Catheter – Product Description 50

Laborie Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 51

T-DOC 5Fr Air-Charged Catheter – Product Status 51

T-DOC 5Fr Air-Charged Catheter – Product Description 51

Leading Age Supplies LLC Pipeline Products & Ongoing Clinical Trials Overview 52

Urinary Catheter – Product Status 52

Urinary Catheter – Product Description 52

Montana State University Pipeline Products & Ongoing Clinical Trials Overview 53

Safety Adaptor For Foley Catheter – Product Status 53

Safety Adaptor For Foley Catheter – Product Description 53

N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 54

CeraShield Urinary Catheter – Product Status 54

CeraShield Urinary Catheter – Product Description 54

Olympus Endo Technology America Inc Pipeline Products & Ongoing Clinical Trials Overview 55

Uro-Ease – Product Status 55

Uro-Ease – Product Description 55

OTU Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 56

NextGen Purewick – Product Status 56

NextGen Purewick – Product Description 56

Portable Purewick – Product Status 57

Portable Purewick – Product Description 57

Purewick No Touch – Product Status 57

Purewick No Touch – Product Description 58

Provenmed Pipeline Products & Ongoing Clinical Trials Overview 59

ActivGo Kit – Product Status 59

ActivGo Kit – Product Description 59

Pyriscence LLC Pipeline Products & Ongoing Clinical Trials Overview 60

Anti-Microbial Catheter – Product Status 60

Anti-Microbial Catheter – Product Description 60

Riocath Global AS Pipeline Products & Ongoing Clinical Trials Overview 61

Epicystostomy Catheter – Product Status 61

Epicystostomy Catheter – Product Description 61

Female Urinary Catheter Permanent – Product Status 62

Female Urinary Catheter Permanent – Product Description 62

Female Urinary Catheter Simple – Product Status 62

Female Urinary Catheter Simple – Product Description 63

Female Urinary Catheter With Insertion Tool – Product Status 63

Female Urinary Catheter With Insertion Tool – Product Description 63

Male Urinary Catheter Permanent – Product Status 64

Male Urinary Catheter Permanent – Product Description 64

Male Urinary Catheter With Insertion Tool – Product Status 64

Male Urinary Catheter With Insertion Tool – Product Description 65

Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 66

Foley Urinary Catheter – Product Status 66

Foley Urinary Catheter – Product Description 66

The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 67

Antimicrobial Catheter – Product Status 67

Antimicrobial Catheter – Product Description 67

Tractivus SL Pipeline Products & Ongoing Clinical Trials Overview 68

UroPHOB urinary catheter – Product Status 68

UroPHOB urinary catheter – Product Description 68

University of Amsterdam Pipeline Products & Ongoing Clinical Trials Overview 69

Percutaneous Nephrostomy Catheter – Product Status 69

Percutaneous Nephrostomy Catheter – Product Description 69

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 70

Urethral Catheter – Product Status 70

Urethral Catheter – Product Description 70

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 71

Urethral Catheter Guidance System – Product Status 71

Urethral Catheter Guidance System – Product Description 71

University of Texas Health Science Center at San Antonio Pipeline Products & Ongoing Clinical Trials Overview 72

Time Sensitive Foley Catheter Alarm – Product Status 72

Time Sensitive Foley Catheter Alarm – Product Description 72

University of Utah Pipeline Products & Ongoing Clinical Trials Overview 73

AdvanceCath Catheter – Product Status 73

AdvanceCath Catheter – Product Description 73

UroDeflect Pipeline Products & Ongoing Clinical Trials Overview 74

Urinary System Catheter – Product Status 74

Urinary System Catheter – Product Description 74

UroDev Medical Pipeline Products & Ongoing Clinical Trials Overview 75

Connected Catheter System – Product Status 75

Connected Catheter System – Product Description 75

UroDev Medical – Ongoing Clinical Trials Overview 76

Connected Catheter System – Evaluation of the Safety and Clinical Performance of the Connected Catheter – Wireless Urinary Prosthesis for Management of Chronic Urinary Retention 77

Xennovate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 78

Vortex ZDS Urinary Retention Catheter – Product Status 78

Vortex ZDS Urinary Retention Catheter – Product Description 78

Glossary 130

Figures

Urinary Catheters – Pipeline Products by Stage of Development 12

Urinary Catheters – Pipeline Products by Segment 13

Urinary Catheters – Pipeline Products by Territory 14

Urinary Catheters – Pipeline Products by Regulatory Path 15

Urinary Catheters – Pipeline Products by Estimated Approval Date 16

Urinary Catheters – Ongoing Clinical Trials 17

Frequently asked questions

Urinary Catheters Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Urinary Catheters Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Urinary Catheters Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Urinary Catheters Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.